Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G

Table 1

General characteristics of liver-derived cell donors.

Donor	Sex	Age	Blood type+rhésus	Cause of death	Type of metabolic disease	Cell type
1	M	33	A+	Cerebral hemorrhage		Hepatocytes
2	F	16	A+	Trauma		Progenitor cells
3	M	18	O+	Trauma (fall)		Progenitor cells
4	M	9	A+	Head trauma		Progenitor cells
5	M	11	O+	Cerebral hemorrhage		Progenitor cells
6	F	48	A+	Stroke		Hepatocytes
7	F	37	A+	Cerebral edema		Progenitor cells
8	F	3	A+	CO poisoning		Hepatocytes
9	F	22 months	A+	Living donor	OCT deficiency	Hepatocytes and progenitor cells
10	F	14 months	A+	Living donor	Type 1B glycogenosis	Hepatocytes
11	F	44	A+	Suicide by hanging		Hepatocytes
12	M	3 days	A+	Respiratory		Progenitor cells
13	F	2	O+	Living donor	Refsum	Hepatocytes and progenitor cells
14	M	7 days	O+	Spinal cord damage following traumatic birth		Hepatocytes and progenitor cells
15	M	4 months	O+	Meningitis (nonsystemic)		Hepatocytes and progenitor cells
16	F	6 days	O+	Severe neonatal asphyxia		Hepatocytes and progenitor cells
17	M	23 months	A+	Living donor	Crigler-Najjar syndrome	Hepatocytes
18	F	48	AB+	Cerebral ischemia		Hepatocytes
19	M	33 months	B+	Living donor	Crigler-Najjar syndrome	Hepatocytes